AlloCure Inc. Begins Phase 2 Clinical Trial in Acute Kidney Injury
9/4/2012 10:01:06 AM
More...
|
AlloCure Inc. Raises $25 Million Series B Venture Financing
4/2/2012 7:21:35 AM
More...
|
AlloCure Inc.’s Investigational Treatment for Acute Kidney Injury Receives Fast Track Designation by FDA
1/5/2012 7:20:56 AM
More...
|
AlloCure Inc. Stem Cell Trial Provides Glimpse of Promising Treatment for Kidney Damage
11/18/2011 8:15:03 AM
More...
|
AlloCure Inc. Presents Safety and Preliminary Efficacy of AC607 for the Treatment of Acute Kidney Injury at American Society of Nephrology
11/14/2011 7:14:31 AM
More...
|
AlloCure Inc. Appoints Kevin J. Heyeck as Chief Business Officer
2/14/2011 8:47:40 AM
More...
|
AlloCure Inc. Names Robert M. Brenner, M.D. Chief Executive Officer
7/6/2010 11:43:29 AM
More...
|
AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury
7/2/2008 11:00:45 AM
More...
|